Risk perception and priority setting for intervention among hepatitis C virus and environmental risks: A cross-sectional survey in the Cairo community

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Schwarzinger, Michal ^a,b   Mohamed, Mostafa K ^c   Gad, Rita R ^c   Dewedar, Sahar ^c   Fontanet, Arnaud ^d   Carrat, Fabrice ^a,e   Luchini, Stéphane ^f  

^a INSERM   (France)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AIN SHAMS UNIVERSITY   (Egypt)

^d INSTITUT PASTEUR   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; COST OF ILLNESS; CROSS-SECTIONAL STUDY; EGYPT; FEMALE; HEALTH CARE DELIVERY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERVIEW; MALE; MIDDLE AGED; PUBLIC HEALTH; RISK ASSESSMENT;

ADULT; ATTITUDE TO HEALTH; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; EGYPT; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PUBLIC HEALTH; RISK ASSESSMENT;

EID: 78650292308     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-773     Document Type: Article

References (50)

1. Process is the point: justice and human rights: priority setting and fair deliberative process. S Gruskin N Daniels, Am J Public Health 2008 98 9 1573 1577 10.2105/AJPH.2007.123182 18633088
2. World Health Report 2000: a step towards evidence-based health policy. C Murray J Frenk, Lancet 2001 357 9269 1698 1700 10.1016/S0140-6736(00)04826-1 11425395
3. Estimates of global and regional potential health gains from reducing multiple major risk factors. M Ezzati SV Hoorn A Rodgers AD Lopez CD Mathers CJ Murray, Lancet 2003 362 9380 271 280 10.1016/S0140-6736(03)13968-2 12892956
4. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. AD Lopez CD Mathers M Ezzati DT Jamison CJ Murray, Lancet 2006 367 9524 1747 1757 10.1016/S0140-6736(06)68770-9 16731270
5. Towards good practice for health statistics: lessons from the Millennium Development Goal health indicators. CJ Murray, Lancet 2007 369 9564 862 873 10.1016/S0140-6736(07)60415-2 17350457
6. National health accounts in developing countries: appropriate methods and recent applications. PA Berman, Health Econ 1997 6 1 11 30 10.1002/(SICI)1099- 1050(199701)6:1<11::AID-HEC238>3.0.CO;2-7 9142528
7. A review of health resource tracking in developing countries. T Powell-Jackson A Mills, Health Policy Plan 2007 22 6 353 362 10.1093/heapol/czm024 17644556
8. Design, content and financing of an essential national package of health services. JL Bobadilla P Cowley P Musgrove H Saxenian, Bull World Health Organ 1994 72 4 653 662 7923544
9. Time to reassess strategies for improving health in developing countries. DB Evans T Adam TT Edejer SS Lim A Cassels TG Evans, BMJ 2005 331 7525 1133 1136 10.1136/bmj.331.7525.1133 16282410
10. Improving child survival through environmental and nutritional interventions: the importance of targeting interventions toward the poor. E Gakidou S Oza C Vidal Fuertes AY Li DK Lee A Sousa MC Hogan S Vander Hoorn M Ezzati, JAMA 2007 298 16 1876 1887 10.1001/jama.298.16.1876 17954539
11. Towards a multi-criteria approach for priority setting: an application to Ghana. R Baltussen E Stolk D Chisholm M Aikins, Health Econ 2006 15 7 689 696 10.1002/hec.1092 16491464
12. Combining evidence and values in priority setting: testing the balance sheet method in a low-income country. E Makundi L Kapiriri OF Norheim, BMC Health Serv Res 2007 7 152 10.1186/1472-6963-7-152 17892561
13. Fairness and accountability for reasonableness. Do the views of priority setting decision makers differ across health systems and levels of decision making? L Kapiriri OF Norheim DK Martin, Soc Sci Med 2009 68 4 766 773 10.1016/j.socscimed.2008.11.011 19070414
14. Basic patterns in national health expenditure. P Musgrove R Zeramdini G Carrin, Bull World Health Organ 2002 80 2 134 142 11953792
15. Targeted health insurance in a low income country and its impact on access and equity in access: Egypt's school health insurance. W Yip P Berman, Health Econ 2001 10 3 207 220 10.1002/hec.589 11288187
16. Inpatient and outpatient health care demand in Cairo, Egypt. RP Ellis DK McInnes EH Stephenson, Health Econ 1994 3 3 183 200 10.1002/hec.4730030307 7921061
17. Egypt National Health Accounts 2001-2002. S Fouad, Bethesda, MD: The Partners for Health Reformplus Project, Abt Associates Inc 2005 1 97
18. Sustainability of USAID-Financed utility Infrastructure Activities in Egypt. DH Pritchard, USAID 2004 1 21 6-263-05-001-S
19. Comparative risk assessment: an international comparison of methodologies and results. RD Morgenstern J Shih SL Sessions, J Hazard Mater 2000 78 1-3 19 39 10.1016/S0304-3894(00)00215-6 10978559
20. Arab Republic of Egypt Cost Assessment of Environmental Degradation. World Bank, Washington, DC: The World Bank 2002 1 37 25175-EGT
21. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. C Frank MK Mohamed GT Strickland D Lavanchy RR Arthur LS Magder T El Khoby Y Abdel-Wahab ES Aly Ohn W Anwar, et al. Lancet 2000 355 9207 887 891 10.1016/S0140-6736(99)06527-7 10752705
22. HCV-related morbidity in a rural community of Egypt. MK Mohamed I Bakr M El-Hoseiny N Arafa A Hassan S Ismail M Anwar M Attala C Rekacewicz K Zalata al et, J Med Virol 2006 78 9 1185 1189 10.1002/jmv.20679 16847958
23. Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt. M Schwarzinger S Dewedar C Rekacewicz KM Abd Elaziz A Fontanet F Carrat MK Mohamed, Hepatology 2004 40 6 1434 1441 10.1002/hep.20468 15565610
24. Diagnosis, management, and treatment of hepatitis C: an update. MG Ghany DB Strader DL Thomas LB Seeff, Hepatology 2009 49 4 1335 1374 10.1002/hep.22759 19330875
25. Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4. H El Makhzangy G Esmat M Said M Elraziky S Shouman R Refai C Rekacewicz RR Gad N Vignier M Abdel-Hamid, et al. J Med Virol 2009 81 9 1576 1583 10.1002/jmv.21570 19626613
26. The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report. N Antaki A Craxi S Kamal R Moucari S Van der Merwe S Haffar A Gadano N Zein CL Lai JM Pawlotsky al et, Liver Int 2010 30 3 342 355 10.1111/j.1478-3231.2009.02188.x 20015149
27. Egyptian National Control Strategy for Viral Hepatitis 2008-2012. National Committee for the Control of Viral Hepatitis, Cairo, Egypt: Ministry of Health and Population 2008 69
28. The discrete-choice willingness-to-pay question format in health economics: should we adopt environmental guidelines? RD Smith, Med Decis Making 2000 20 2 194 206 10.1177/0272989X0002000205 10772357
29. Eliciting several willingness to pay in a single contingent valuation survey: application to health care. S Luchini C Protiere JP Moatti, Health Econ 2003 12 1 51 64 10.1002/hec.703 12483760
30. Comparison of four contingent valuation methods to estimate the economic value of a pneumococcal vaccine in Bangladesh. RR Heinzen JF Bridges, Int J Technol Assess Health Care 2008 24 4 481 487 10.1017/S026646230808063X 18828944
31. The Perception of Risk. P Slovic, London: Earthscan Publication Ltd 2000
32. Valuing mortality-risk reduction: using visual aids to improve the validity of contingent valuation. PS Corso JK Hammitt JD Graham, J Risk Uncertain 2001 23 2 165 184 10.1023/A:1011184119153
33. On least squares estimation when the dependent variable is grouped. MB Stewart, Review of Economic Studies 1983 50 737 753 10.2307/2297773
34. SO2 levels in Cairo. EIMP, Cairo: Ministry of State for Environmental Affairs, Egyptian Environmental Affairs Agency (EEAA), Environmental Information and Monitoring Programme (EIMP) 2000 1 2
35. A nonmetric variety of linear factor analysis. JB Kruskal RN Shepard, Psychometrika 1974 38 123 157 10.1007/BF02291465
36. Voting Procedures. S Brams P Fishburn, Handbook of Social Choice and Welfare Elsevier, Arrow K, Sen AK, Suzumura K, 2002 1 10.1016/S1574-0110(02) 80008-X
37. Egypt Demographic and Health Survey 2005. F El-Zanaty A Way, Cairo, Egypt: Ministry of Health and Population, National Population Council, El-Zanaty and Associates, and ORC Macro 364
38. Risk perception in a developing country: the case of Chile. NC Bronfman LA Cifuentes, Risk Anal 2003 23 6 1271 1285 10.1111/j.0272-4332.2003.00400.x 14641900
39. A new look at the psychometric paradigm of perception of hazards. M Siegrist C Keller HA Kiers, Risk Anal 2005 25 1 211 222 10.1111/j.0272-4332. 2005.00580.x 15787770
40. Air Quality Guidelines: Global Update 2005. Particulate matter, ozone, nitrogen dioxide and sulfur dioxide. WHO, Geneva: World Health Organization 2006
41. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. C Hezode N Forestier G Dusheiko P Ferenci S Pol T Goeser JP Bronowicki M Bourliere S Gharakhanian L Bengtsson, et al. N Engl J Med 2009 360 18 1839 1850 10.1056/NEJMoa0807650 19403903
42. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. JG McHutchison GT Everson SC Gordon IM Jacobson M Sulkowski R Kauffman L McNair J Alam AJ Muir, N Engl J Med 2009 360 18 1827 1838 10.1056/NEJMoa0806104 19403902
43. Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial. PY Kwo EJ Lawitz J McCone ER Schiff JM Vierling D Pound MN Davis JS Galati SC Gordon N Ravendhran, et al. Lancet 2010 376 9742 705 716 10.1016/S0140-6736(10)60934-8 20692693
44. How much disease burden can be prevented by environmental interventions? A Pruss-Ustun C Corvalan, Epidemiology 2007 18 1 167 178 10.1097/01.ede. 0000239647.26389.80 16971860
45. Can the value choices in DALYs influence global priority-setting? T Arnesen L Kapiriri, Health Policy 2004 70 2 137 149 10.1016/j.healthpol.2003.08. 004 15364144
46. Multiple-informant ranking of the disabling effects of different health conditions in 14 countries. WHO/NIH Joint Project CAR Study Group. TB Ustun J Rehm S Chatterji S Saxena R Trotter R Room J Bickenbach, Lancet 1999 354 9173 111 115 10.1016/S0140-6736(98)07507-2 10408486
47. The impact of the environment on health by country: a meta-synthesis. A Pruss-Ustun S Bonjour C Corvalan, Environ Health 2008 7 7 10.1186/1476-069X-7-7 18298819
48. Can we achieve health information for all by 2015? F Godlee N Pakenham-Walsh D Ncayiyana B Cohen A Packer, Lancet 2004 364 9430 295 300 10.1016/S0140-6736(04)16681-6 15262109
49. Misfinancing global health: a case for transparency in disbursements and decision making. D Sridhar R Batniji, Lancet 2008 372 9644 1185 1191 10.1016/S0140-6736(08)61485-3 18926279
50. The global health system: lessons for a stronger institutional framework. S Moon NA Szlezak CM Michaud DT Jamison GT Keusch WC Clark BR Bloom, PLoS Med 2010 7 1 1000193 10.1371/journal.pmed.1000193 20126249